These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21399493)

  • 1. The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine?
    Blankson JN
    Curr Opin HIV AIDS; 2011 May; 6(3):147-50. PubMed ID: 21399493
    [No Abstract]   [Full Text] [Related]  

  • 2. Elite controllers as a model of functional cure.
    Autran B; Descours B; Avettand-Fenoel V; Rouzioux C
    Curr Opin HIV AIDS; 2011 May; 6(3):181-7. PubMed ID: 21460722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do HIV elite controllers do what they do?
    Saag M; Deeks SG
    Clin Infect Dis; 2010 Jul; 51(2):239-41. PubMed ID: 20550453
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV-1 elite controllers: beware of super-infections.
    Clerc O; Colombo S; Yerly S; Telenti A; Cavassini M
    J Clin Virol; 2010 Apr; 47(4):376-8. PubMed ID: 20153976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 and AIDS: what are protective immune responses?
    Beattie T; Rowland-Jones S; Kaul R
    J HIV Ther; 2002 May; 7(2):35-9. PubMed ID: 12553686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new veil removed from the physiologic mysteries of "HIV control" ].
    Nau JY
    Rev Med Suisse; 2007 Apr; 3(107):1017. PubMed ID: 17526378
    [No Abstract]   [Full Text] [Related]  

  • 7. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
    Sheppard N; Sattentau Q
    Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL; Hahn BH
    AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine to prevent AIDS.
    Tyring S
    Res Initiat Treat Action; 1999 Jan; 5(1):9-10. PubMed ID: 11366234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 13. Elucidating the elite: mechanisms of control in HIV-1 infection.
    O'Connell KA; Bailey JR; Blankson JN
    Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine to prevent AIDS overstated.
    Lewis D
    Res Initiat Treat Action; 1999 Jan; 5(1):11-2. PubMed ID: 11366223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.
    Albert J; Chiodi F; Fenyö EM
    J Intern Med; 2007 Jul; 262(1):2-4. PubMed ID: 17598811
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine fundamentals.
    Simmons P
    Res Initiat Treat Action; 1999 Jan; 5(1):8. PubMed ID: 11366233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological considerations in the development of a human immunodeficiency virus vaccine.
    Nathanson N; Mathieson BJ
    J Infect Dis; 2000 Aug; 182(2):579-89. PubMed ID: 10915092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 superinfection--a word of caution.
    Goulder PJ; Walker BD
    N Engl J Med; 2002 Sep; 347(10):756-8. PubMed ID: 12213949
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prospects for vaccine development against HIV infection].
    Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
    Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.